Drug Type Small molecule drug |
Synonyms |
Mechanism κ opioid receptor agonists(Kappa opioid receptor agonists), μ opioid receptor agonists(Mu opioid receptor agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization Inversago Pharma, Inc.Startup |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 1 |
First Approval Date- |
Regulation- |
Molecular FormulaC29H37NO8S |
InChIKeyGFFDXKKSLGNXFJ-UHFFFAOYSA-N |
CAS Registry1456509-49-1 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Analgesia | Phase 1 | CA | 01 Oct 2014 | |
Analgesia | Phase 1 | CA | 01 Oct 2014 | |
Visceral Pain | Phase 1 | CA | 01 Oct 2014 | |
Visceral Pain | Phase 1 | CA | 01 Oct 2014 |